PreciseDx
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$20.7M
PreciseDx is a company that uses AI-driven technology to provide detailed diagnostics and risk assessments for oncology, particularly focusing on breast cancer.
Focus Areas
AI-driven
oncology diagnostics
risk assessment
Morphology Feature Array
cancer care
disease insights
Investors
